1Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence,prognosis, and predispeeing conditions for atrial fibrillation:Population- based estimates (J) .Am J Cardiol, 1998,82:2NN.
2Skanes AC,Krahn AD, Yee R, et al. Progression to chronic atrial fibrillation After pacing. The Canadinu Trial of physiologic pacing.J Am Coll Cardiol,2001 ;38(1) :167 - 172.
3Mark M, Gallagher and John Camm. Classification of atrial fibrillation.Am J Cardiol, 1998,82:18N - 28N.
4Tse HF, Lau CP, Sra JS,et al.Atrlal fibrillation detection and R- wave Synchronization by Metrix implantion atrial defibrillator. Implications for long- term efficacy and safety. Circulation, 1999,99:1446- 1451.
5Trappe HJ, Achetlik M, Pfitzner P, et al. Sinngle - chamber versus dual- chamber implantable cardioverter defibrillators: Indications and clinical results.Am J Cardiol,1999,83:8D.
6Packer M, Colin JN. Consensus recommendations for the management of chronicheart failure.Am J Cardiol,1999,83: 1A- 5A.
7Gras D, Mabo P, Yang T, et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Insyne Study, Pace , 1998,21 : 2249.
8Cazean S, Leclerco C, Lavergne T, et al. Effecte of multisite biventricular pacing in patients with heart fuilure and intraventricular conduction delay. N Engl J Med, 2001,344(12) : 873 - 880.
9Ammirati F,Colivicichi F,Santini M,et al.Permanent cardial pacing versus medical treatment for the prevention of recurrent vasovagal syncope. Circulation ,2001,104( 1 ) :52 - 57.
10Femou AM, Hammil SC, Rea RF, et al. Vasovagal syncope.Ann Intern Med ,2000,133:714-725.
